Insider Transactions in Q3 2021 at Global Blood Therapeutics, Inc. (GBT)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 09
2021
|
Scott W Morrison Director |
SELL
Open market or private sale
|
Direct |
4,800
-61.25%
|
$144,000
$30.21 P/Share
|
|
Sep 01
2021
|
Ted W Love President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,683
-0.59%
|
$135,807
$29.85 P/Share
|
|
Sep 01
2021
|
Ted W Love President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,444
+1.17%
|
-
|
|
Sep 01
2021
|
Jeffrey S Farrow Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,370
-6.0%
|
$39,730
$29.85 P/Share
|
|
Sep 01
2021
|
Jeffrey S Farrow Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,762
+10.79%
|
-
|
|
Sep 01
2021
|
Tricia Borga Suvari Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,047
-3.67%
|
$30,363
$29.85 P/Share
|
|
Sep 01
2021
|
Tricia Borga Suvari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,762
+8.83%
|
-
|
|
Sep 01
2021
|
David Lee Johnson Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,072
-2.83%
|
$31,088
$29.85 P/Share
|
|
Sep 01
2021
|
David Lee Johnson Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,762
+6.79%
|
-
|
|
Sep 01
2021
|
Jung Choi Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,370
-0.74%
|
$39,730
$29.85 P/Share
|
|
Sep 01
2021
|
Jung Choi Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,762
+1.47%
|
-
|
|
Aug 31
2021
|
Tricia Borga Suvari Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43
+0.17%
|
$1,032
$24.39 P/Share
|
|
Aug 31
2021
|
David Lee Johnson Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
480
+1.35%
|
$11,520
$24.39 P/Share
|
|
Aug 31
2021
|
Jung Choi Officer |
BUY
Grant, award, or other acquisition
|
Direct |
128
+0.07%
|
$3,072
$24.39 P/Share
|
|
Aug 01
2021
|
Tricia Borga Suvari Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,250
-11.22%
|
$87,750
$27.33 P/Share
|
|
Aug 01
2021
|
Tricia Borga Suvari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,395
+24.49%
|
-
|
|
Aug 01
2021
|
David Lee Johnson Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,342
-6.32%
|
$63,234
$27.33 P/Share
|
|
Aug 01
2021
|
David Lee Johnson Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,770
+15.45%
|
-
|
|
Aug 01
2021
|
Jeffrey S Farrow Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,354
-17.83%
|
$117,558
$27.33 P/Share
|
|
Aug 01
2021
|
Jeffrey S Farrow Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,020
+26.97%
|
-
|
|
Aug 01
2021
|
Jung Choi Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,743
-2.01%
|
$101,061
$27.33 P/Share
|
|
Aug 01
2021
|
Jung Choi Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,020
+4.62%
|
-
|
|
Aug 01
2021
|
Ted W Love President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,853
-1.85%
|
$401,031
$27.33 P/Share
|
|
Aug 01
2021
|
Ted W Love President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
29,955
+3.59%
|
-
|